SITC Immunotherapy Guidelines 1.7

The Society for Immunotherapy of Cancer (SITC) Clinical Practice Guidelines (CPG) Mobile App provides clinicians with a valuable resource for accessing SITC's CPGs conveniently on their phones or tablets. This innovative app offers evidence-based and expert consensus recommendations on various aspects of immunotherapy treatment, along with interactive tools and educational resources.

With a clean and modern interface, the SITC CPG App allows for easy navigation. Clinicians can access interactive tools and tables quickly, thanks to the advanced search functionality. The ability to bookmark and make annotations enables fast-reference for future use. Additionally, timely updates are provided to inform users of new practice-changing data and approvals. The app also offers companion educational materials to enhance understanding of guideline recommendations.

SITC's Clinical Practice Guidelines (CPGs) serve as a vital resource for oncology professionals, providing practical and actionable recommendations for developing immunotherapy treatment plans. These guidelines are developed by multi-disciplinary panels of experts who draw from their own practical experience, as well as published literature and clinical trial data. SITC follows the Institute of Medicine's "Standards for Developing Trustworthy Clinical Practice Guidelines" to ensure a fair and transparent process for creating the CPGs.

SITC is a 501(c)(3) not-for-profit medical professional society dedicated to improving cancer patient outcomes through the advancement of cancer immunotherapy. Comprised of influential research scientists, clinicians, patients, advocates, government representatives, and industry leaders, SITC strives to make the word "cure" a reality for cancer patients worldwide.

For more information about SITC's Clinical Practice Guidelines Mobile App, visit sitcancer.org/CPG-app. Join the conversation using #SITCGuidelines on social media.